Anterix closed fiscal year 2026 with $98 million in cash and no debt on its balance sheet, a notable financial position for a company still in the commercial ramp phase of spectrum monetization. The $127 million in cash collected during the year, well above the $80 million analyst estimate, signals strong demand realization rather than just bookings. A debt-free structure limits financial risk even as the company continues investing in customer acquisition and spectrum deployment support. Investors appear to be pricing in the scarcity premium of Anterix's 900 MHz FCC-licensed spectrum as a durable moat.
Anterix (NASDAQ: ATEX) Ends Fiscal 2026 with Zero Debt and $98 Million Cash: Is ATEX a Strong Balance Sheet Buy?
Image Source: shutterstock
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsKalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.





-Copy_06_12_2026_01_01_22_773704.jpg)
Please wait processing your request...